Diabetes, Gestational Clinical Trial
Official title:
Meals for Moms: A Postpartum Medically-Tailored Meal Program to Promote Weight Loss and Blood Glucose Control Among Women With Hyperglycemia in Pregnancy
Verified date | February 2023 |
Source | Wake Forest University Health Sciences |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this research study is to test whether delivery of medically tailored meals (meals designed specifically to be healthy) can be used to help reduce high blood sugar after delivery of a baby. Participants will be recruited and consented during the third trimester of pregnancy but will begin study activities after delivery. Participants will complete a series of questionnaires on demographics, health history, home environment, overall and financial stress, plans for weight loss and infant feeding, and food insecurity. Participants will also be asked to wear continuous glucose monitors for two separate 14-day periods (within 2 weeks of delivery and at 3 months). All participants will receive weekly emails with educational videos and 3 virtual visits with a member of the study team and will also be randomly assigned to an intervention or comparison group. In the intervention, participants will receive weekly meal deliveries of 10 pre-prepared meals from Providence Community Kitchen (local company in Winston-Salem, NC) that are calorically restricted and appropriate for post-partum women with a history of gestational diabetes and who may be breast-feeding. Women in the control condition will receive written resources on self-care, nutrition, and physical activity appropriate for post-partum women who had gestational diabetes.
Status | Completed |
Enrollment | 12 |
Est. completion date | January 17, 2023 |
Est. primary completion date | January 17, 2023 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Demographics: Women 18 years of age and older who reside in Forsyth County, NC - Pregnancy: Currently 24 or more weeks into a singleton pregnancy - Clinical evidence of gestational diabetes mellitus (GDM) defined as either 3-hour oral glucose tolerance test (OGTT) results obtained in the second trimester of pregnancy that show at least 2 abnormal values or a diagnosis of "gestational diabetes" included on the Problem List in medical record during current pregnancy, regardless of OGTT values - Excessive gestational weight gain: Most recent weight exceeds predicted weight gain for current weeks gestational age defined as pre-pregnancy Body mass index (BMI) of 30 kg/m2 or more and weight at most recent clinical visit 20+ pounds over pre-pregnancy weight or pre-pregnancy BMI of 25-29.9 kg/m2 and weight at most recent clinical visit 25+ pounds over pre-pregnancy weight - English Proficiency: Able to read/understand English at or above a level sufficient to comprehend recruitment, informed consent, and intervention materials. - Access to a smart phone/tablet/computer capable of connecting to video calls or teleconferencing software. - Willingness to Accept Randomization: Prospective participants must be willing to accept randomization to either the medically tailored meal intervention or the comparison intervention condition. Exclusion Criteria: - Clinical history of diabetes (type 1 or 2) pre-pregnancy - Non-singleton pregnancy - Other chronic diseases or medical conditions that would increase risk or make participation otherwise unsafe, including special dietary needs. A clinician investigator will review the medical record for all potential participants to determine if any such conditions exist. - Known food allergies of sensitivities. Potential participants who report special dietary requirements including vegetarians, vegans, those who follow kosher or other specialized diets will be excluded due to the small nature of this pilot study. - History of allergic skin reaction to adhesive tape - Unable or unwilling to wear a continuous glucose monitor (CGM) device - Is scheduled for an MRI during the study weeks, making use of the CGM device unsafe - Other: Conditions/criteria likely to interfere with participation and acceptance of randomized assignment, including the following: inability/unwillingness to give informed consent, major psychiatric or cognitive problems (schizophrenia, dementia, self-reported substance or alcohol abuse), participation in another research study that would interfere with Meals for Moms |
Country | Name | City | State |
---|---|---|---|
United States | Wake Forest Baptist Health | Winston-Salem | North Carolina |
Lead Sponsor | Collaborator |
---|---|
Wake Forest University Health Sciences | North Carolina Diabetes Research Center, University of North Carolina, Chapel Hill |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Feasibility of Medically Tailored Meals in Postpartum Mothers: Percent of meals successfully Ordered and Delivered | Determine the percent of meals successfully ordered & delivered in the intervention group | 3 months | |
Primary | Feasibility of Medically Tailored Meals in Postpartum Mothers: Cost per Participant | Determine an approximate cost for the medically tailored meal program per participant | 3 months | |
Primary | Days of Continuous Glucose Monitoring in Postpartum Mothers | Tracking the number of days the continuous glucose monitors were worn (of 14 total possible) at baseline. | Baseline | |
Primary | Days of Continuous Glucose Monitoring in Postpartum Mothers | Tracking the number of days the continuous glucose monitors were worn (of 14 total possible) at 3 months. | 3 months | |
Primary | Acceptability of Study Measures | Using qualitative interviews, assess how acceptable the target population found the proposed data collection measures to be - collecting feedback from subjects to plan for a larger trial. | 3 months | |
Secondary | Change in Mean Glucose | Using data from the continuous glucose monitor, changes in mean glucose will be assessed | Baseline and month 3 | |
Secondary | Change in Glucose Management Indicator (GMI) | Using data from the continuous glucose monitor, changes in GMI will be assessed as a proxy measure of hemoglobin A1c | Baseline and month 3 | |
Secondary | Change in Glycemic Variability | Using data from the continuous glucose monitor, changes in glycemic variability (percent coefficient of variation) will be assessed | Baseline and month 3 | |
Secondary | Change in Time in Range (TIR) | Using data from the continuous glucose monitor, changes in percent of time in range (70 mg/dL to 180 mg/dL) will be assessed | Baseline and month 3 | |
Secondary | Change in Time Above Range (Hyperglycemia) | Using data from the continuous glucose monitor, changes in percent of time above the target range (70 mg/dL to 180 mg/dL) will be assessed | Baseline and month 3 | |
Secondary | Change in Time Below Range (Hypoglycemia) | Using data from the continuous glucose monitor, changes in percent of time below the target range (70 mg/dL to 180 mg/dL) will be assessed | Baseline and month 3 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02577536 -
PregSource: Crowdsourcing to Understand Pregnancy
|
||
Not yet recruiting |
NCT06437782 -
Exploration of Health Literacy in Diabetes in Reunion Island and France
|
||
Completed |
NCT01940003 -
Effects of an Aquatic Physical Exercise Program on Glycaemic Control and Perinatal Outcomes of Gestational Diabetes: Study Protocol for a Randomized Controlled Trial
|
N/A | |
Completed |
NCT02960295 -
The Virtual Visit for Women With Gestational Diabetes
|
N/A | |
Completed |
NCT01919476 -
Postprandial Response to Almond Consumption in Overweight Hispanic Pregnant Women
|
N/A | |
Completed |
NCT05512871 -
A Mobile Health-enabled Lifestyle Intervention Among Women With History of Gestational Diabetes(GDM)
|
N/A | |
Enrolling by invitation |
NCT03307486 -
Gestational Diabetes: a Cohort Study
|
N/A | |
Active, not recruiting |
NCT04417452 -
Long-term Outcome After Gestational Diabetes and Diabetes in Pregnancy
|
||
Completed |
NCT02968628 -
Effect of Maternal Diabetes on Brain Development, as Measured by Neonatal Electroencephalogram (EEG)
|
||
Active, not recruiting |
NCT04222348 -
MeDiGes Study: Metformine Use in Gestational Diabetes
|
Phase 3 | |
Completed |
NCT03007186 -
Glucose Monitoring During Threatening Preterm Birth in Patients With and Without Gestational Diabetes Mellitus
|
||
Completed |
NCT00069576 -
Gestational Diabetes Mellitus Trial (GDM)
|
N/A | |
Recruiting |
NCT04198857 -
Development and Testing of a Mobile Health Application for Management of Gestational Diabetes
|
N/A | |
Recruiting |
NCT05115188 -
DIAgnosing GDM usiNg Oral Sugar InStead
|
Phase 2 | |
Recruiting |
NCT03607799 -
A Culturally-tailored Personalized Nutrition Intervention in South Asian Women at Risk of Gestational Diabetes
|
N/A | |
Recruiting |
NCT02893072 -
Medical Nutrition Therapy Intervention Program for Women With Gestational Diabetes--a Prospective Study
|
N/A | |
Enrolling by invitation |
NCT05368220 -
Translating Genetic Knowledge Into Clinical Care in Non-Autoimmune Diabetes
|
||
Completed |
NCT02770079 -
Insulin Sensitivity and Secretion During Pregnancy and Post Partum in Women With Gestational Diabetes.
|
||
Completed |
NCT00681460 -
Metformin in Gestational Diabetes Mellitus
|
N/A | |
Recruiting |
NCT03117543 -
Diagnostic Approaches in Gestational Diabetes and Impact of Ethnicity
|